top of page
News & Events
Boston ONS supports oncology programs and is now offering event management packages to best suit your program needs. Check it out!
- Sat, Dec 13
Search
TAZVERIK (tazemetostat) ~ Relapsed or Refractory Follicular Lymphoma
Don't miss this new upcoming event! Click image above to register! Event flyer attached below.
Jan 6, 20211 min read
TAZVERIK ~ Now Approved ~ Virtual Talk Thursday, 12/10/20 @ 5:00PM
TAZVERIK™ (tazemetostat) is indicated for the treatment of:∙Adult patients with relapsed or refractory follicular lymphoma whose tumors...
Dec 5, 20201 min read
Nov 19, 20200 min read
A Treatment Option for the Management of Patients With First-Line NSCLC & Metastatic Melanoma
A Treatment Option for the Management of Certain Patients with First-Line NSCLC & Unresectable Metastatic Melanoma VIRTUAL EVENT Click on...
Nov 2, 20201 min read
BONS Members ONLY ~ New Evidence in First-Line AML & Exploring Outcomes
BONS Members ONLY! Click date links below to REGISTER through Boston ONS. Tuesday, November 10th 5PM Tuesday, November 10th 8PM Thursday,...
Oct 28, 20202 min read
Combining the HER2+ Breast Cancer Antibodies You Know in One Fixed-Dose Subcutaneous Injection ~ NEW
PROGRAM OBJECTIVES: Provide product overview including indication, important safety information, dosing, and administration Review...
Oct 28, 20201 min read
Introducing BLENREP (belantamab mafodotin-blmf) ~
Presented by Jamie Mortellite, MSN, ACNP-BC GlaxoSmithKline Date and Time October 20th @ 6:30PM RSVP Jamie Mortellite @...
Oct 11, 20201 min read
IMBRUVICA (IBRUTINIB) With A Focus on Walsenstrom's Macroglobulinemia (WM) ~ TOMORROW @ 12:15pm
Click on either image above to link directly to registration!
Oct 7, 20201 min read
A Treatment Option for the Management of Certain Patients With First-Line Non-Small Cell Lung Cancer
You are cordially invited by your Bristol Myers Squibb representative to attend a product presentation that will focus on: A Treatment...
Sep 30, 20201 min read
Protecting Patients with NERLYNX the only HER2-directed small molecule approved by the FDA ~ Oct 7th
PLEASE REGISTER ONLINE AT: PUMAREG.TSGMEDED.COM Enter Event Code:51684 This program is sponsored by Puma Biotechnology, Inc. This is not...
Sep 30, 20201 min read
FRONTLINE ADVANCEMENTS:CLINICAL DATA OVERVIEW OF ECHELON-1
Seattle Genetics cordially invites you to an educational program FRONTLINE ADVANCEMENTS: CLINICAL DATA OVERVIEW OF ECHELON-1 Join us to...
Sep 30, 20201 min read
NEW EVENT! Importance of Bone Targeting Agents in Metastatic Breast Cancer
REGISTER NOW! This is a non-CME presentation and is not eligible for AMA PRA Category 1 CreditsTM Online Program Sponsored by Amgen, Inc....
Sep 16, 20201 min read
NEW EVENT! Learn more about TAZVERIK at this virtual event!
TAZVERIK™ (tazemetostat) is indicated for the treatment of:•Adult patients with relapsed or refractory follicular lymphoma whose tumors...
Sep 16, 20201 min read
Reigniting Research: A Call to Action to Advance Cancer Research and Innovation
Monday, October 26, 2020 - 3:00pm to 4:30pm ACS CAN 2020 Research Breakfast - A Virtual Event U.S. National Cancer Institute Director Dr....
Sep 9, 20202 min read
PADCEV ~ enfortumab vedotin-eifv ~ SEPT 29th ~ Don't miss it!
YOU ARE CORDIALLY INVITED TO A VIRTUAL PROGRAM A program on an FDA-approved treatment option in locally advanced or mUC for patients who...
Sep 9, 20201 min read
Emerging Roles for MRD in the Management of GI Cancer ~ Tuesday, September 22 ~ 6PM
Natera would like to invite you to a virtual program with Samuel Klempner, MD, GI Medical Oncologist from Massachusetts General Hospital...
Sep 2, 20201 min read
NEW WEBCAST!
Please note this program is intended for healthcare professionals (HCPs) only. This program is sponsored by MorphoSys US Inc and Incyte...
Sep 1, 20203 min read
PADCEV (enfortumab vedotin-ejfv) Injection for IV infusion ~ Virtual Event
PRESENTER Bethany Mooney, CRNP W/PA University of Pennsylvania Philadelphia, PA Kindly Reply by August 18, 2020 In the RSVP, please...
Aug 18, 20201 min read
Therapy for Patients with Previously Treated Metastatic Colorectal Cancer (mCRC)
INDICATION STIVARGA is indicated for the treatment of patients with mCRC who have been previously treated with fluoropyrimidine-,...
Jul 31, 20201 min read
bottom of page